Liquid Biopsy for Cancer: Review and Implications for the Radiologist
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Imaging and image-guided procedures play an imperative role in the screening, diagnosis, and surveillance of cancer. Although emerging imaging techniques now enable more precise molecular characterization of tumors, multigenetic tumor profiling for targeted therapeutic selection remains limited to direct tissue acquisition. Even in the context of targeted therapy, tumors adapt to acquire resistance. This necessitates serial monitoring, traditionally through tissue acquisition, to identify the molecular mechanism of resistance and to guide second-line therapy. An alternative to tissue acquisition is the collection of circulating tumor markers such as cell-free nucleic acids and circulating tumor cells in the peripheral blood. This noninvasive diagnostic approach is referred to as the liquid biopsy. The liquid biopsy is currently used clinically for therapeutic guidance when tissue acquisition is impossible or when the specimen is inadequate. It is also being studied in the context of screening, diagnosis, and surveillance. As cancer treatment continues to move toward a focus on precision medicine, this developing technology may alter and/or augment the role of imaging in the management of cancer. This review aims to outline the use of liquid biopsy in cancer and its potential impact on diagnostic imaging and image-guided procedures.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a highly sensitive liquid biopsy methodology, NGS-based ctDNA detection can enable the identification of tumor relapse earlier than traditional radiological examinations, thereby facilitating prompt treatment decisions.8, 9, 10”
From Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma (2024) · cites this paper as [8]
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Circulating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K., Goodman, S., Li, M., Thornton, K., Agrawal, N., Sokoll, L., Szabo, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,734
Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,632
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542
Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Douillard, J.-Y., Oliner, K. S., Siena, S., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305275 · Cited by 2,263
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220
de Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W. W. M., Pienta, K. J., & Raghavan, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0872 · Cited by 2,182
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Misale, S., Yaeger, R., Hobor, S., Scala, E., Janakiraman, M., Liska, D., Valtorta, E., Schiavo, R., Buscarino, M., Siravegna, G., et al. (2012) · Nature · doi:10.1038/nature11156 · Cited by 1,889
Cohen, S. J., Punt, C. J. A., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E., Miller, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8923 · Cited by 1,841
Cristofanilli, M., Turner, N. C., Bondarenko, I., Ro, J., Im, S.-A., Masuda, N., Colleoni, M., DeMichele, A., Loi, S., Verma, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00613-0 · Cited by 1,827
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
The Eighth Edition Lung Cancer Stage Classification
Detterbeck, F. C., Boffa, D. J., Kim, A. W., & Tanoue, L. T. (2017) · Chest · doi:10.1016/j.chest.2016.10.010 · Cited by 1,641
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Murtaza, M., Dawson, S.-J., Tsui, D. W. Y., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A. S. C., et al. (2013) · Nature · doi:10.1038/nature12065 · Cited by 1,624
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
Maheswaran, S., Sequist, L. V., Nagrath, S., Ulkus, L., Brannigan, B., Collura, C. V., Inserra, E., Diederichs, S., Iafrate, A. J., Bell, D. W., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800668 · Cited by 1,617
Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6219 · Cited by 1,492
Riethdorf, S., Fritsche, H., Müller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,338
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R. J., Cheang, M., Osin, P., Nerurkar, A., Kozarewa, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0021 · Cited by 1,150
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A., Reuben, J. M., Doyle, G. V., Matera, J., Allard, W. J., Miller, M. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.140 · Cited by 1,135
Circulating Tumor Cells in Patients with Breast Cancer Dormancy
Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., Beitsch, P. D., Leitch, M., Hoover, S., Euhus, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1110 · Cited by 971
Origins, structures, and functions of circulating DNA in oncology
Thierry, A. R., El Messaoudi, S., Gahan, P. B., Anker, P., & Stroun, M. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9629-x · Cited by 818
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer
Fribbens, C., O’Leary, B., Kilburn, L., Hrebien, S., Garcia-Murillas, I., Beaney, M., Cristofanilli, M., Andre, F., Loi, S., Loibl, S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.3061 · Cited by 722
Lanman, R. B., Mortimer, S. A., Zill, O. A., Sebisanovic, D., Lopez, R., Blau, S., Collisson, E. A., Divers, S. G., Hoon, D. S. B., Kopetz, E. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140712 · Cited by 695
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
Thierry, A. R., Mouliere, F., El Messaoudi, S., Mollevi, C., Lopez-Crapez, E., Rolet, F., Gillet, B., Gongora, C., Dechelotte, P., Robert, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3511 · Cited by 678
Identification of tissue-specific cell death using methylation patterns of circulating DNA
Lehmann-Werman, R., Neiman, D., Zemmour, H., Moss, J., Magenheim, J., Vaknin-Dembinsky, A., Rubertsson, S., Nellgård, B., Blennow, K., Zetterberg, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519286113 · Cited by 610
Leighl, N. B., Page, R. D., Raymond, V. M., Daniel, D. B., Divers, S. G., Reckamp, K. L., Villalona-Calero, M. A., Dix, D., Odegaard, J. I., Lanman, R. B., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0624 · Cited by 587
Impact of the physical microenvironment on tumor progression and metastasis
Spill, F., Reynolds, D. S., Kamm, R. D., & Zaman, M. H. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.02.007 · Cited by 581
Arcila, M. E., Oxnard, G. R., Nafa, K., Riely, G. J., Solomon, S. B., Zakowski, M. F., Kris, M. G., Pao, W., Miller, V. A., & Ladanyi, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2277 · Cited by 574
Thress, K. S., Brant, R., Carr, T. H., Dearden, S., Jenkins, S., Brown, H., Hammett, T., Cantarini, M., & Barrett, J. C. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.10.004 · Cited by 493
Tomiyama, N., Yasuhara, Y., Nakajima, Y., Adachi, S., Arai, Y., Kusumoto, M., Eguchi, K., Kuriyama, K., Sakai, F., Noguchi, M., et al. (2006) · European Journal of Radiology · doi:10.1016/j.ejrad.2006.02.001 · Cited by 492
Taly, V., Pekin, D., Benhaim, L., Kotsopoulos, S. K., Le Corre, D., Li, X., Atochin, I., Link, D. R., Griffiths, A. D., Pallier, K., et al. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.206359 · Cited by 492
Aggarwal, C., Thompson, J. C., Black, T. A., Katz, S. I., Fan, R., Yee, S. S., Chien, A. L., Evans, T. L., Bauml, J. M., Alley, E. W., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4305 · Cited by 486
Sausen, M., Phallen, J., Adleff, V., Jones, S., Leary, R. J., Barrett, M. T., Anagnostou, V., Parpart-Li, S., Murphy, D., Kay Li, Q., et al. (2015) · Nature Communications · doi:10.1038/ncomms8686 · Cited by 484
Genetic heterogeneity and cancer drug resistance
Turner, N. C., & Reis-Filho, J. S. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70335-7 · Cited by 454
Douillard, J.-Y., Ostoros, G., Cobo, M., Ciuleanu, T., Cole, R., McWalter, G., Walker, J., Dearden, S., Webster, A., Milenkova, T., et al. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000263 · Cited by 448
Drilon, A., Nagasubramanian, R., Blake, J. F., Ku, N., Tuch, B. B., Ebata, K., Smith, S., Lauriault, V., Kolakowski, G. R., Brandhuber, B. J., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0507 · Cited by 439
Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer
Hou, J.-M., Krebs, M., Ward, T., Sloane, R., Priest, L., Hughes, A., Clack, G., Ranson, M., Blackhall, F., & Dive, C. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.12.003 · Cited by 426
Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
Russo, M., Siravegna, G., Blaszkowsky, L. S., Corti, G., Crisafulli, G., Ahronian, L. G., Mussolin, B., Kwak, E. L., Buscarino, M., Lazzari, L., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1283 · Cited by 405
Imaging diagnosis of pancreatic cancer: A state-of-the-art review
Lee, E. S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7864 · Cited by 401
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
Hu, Z. I., Shia, J., Stadler, Z. K., Varghese, A. M., Capanu, M., Salo-Mullen, E., Lowery, M. A., Diaz, L. A., Mandelker, D., Yu, K. H., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3099 · Cited by 372
Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer
Tanaka, F., Yoneda, K., Kondo, N., Hashimoto, M., Takuwa, T., Matsumoto, S., Okumura, Y., Rahman, S., Tsubota, N., Tsujimura, T., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1095 · Cited by 333
O’Neil, B. H., Wallmark, J. M., Lorente, D., Elez, E., Raimbourg, J., Gomez-Roca, C., Ejadi, S., Piha-Paul, S. A., Stein, M. N., Abdul Razak, A. R., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0189848 · Cited by 296
Molecularly targeted cancer therapy: some lessons from the past decade
Huang, M., Shen, A., Ding, J., & Geng, M. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.11.004 · Cited by 291
Pailler, E., Adam, J., Barthélémy, A., Oulhen, M., Auger, N., Valent, A., Borget, I., Planchard, D., Taylor, M., André, F., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.5932 · Cited by 284
Epithelial-Mesenchymal Transition in tumor microenvironment
Jing, Y., Han, Z., Zhang, S., Liu, Y., & Wei, L. (2011) · Cell & Bioscience · doi:10.1186/2045-3701-1-29 · Cited by 270
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
Khoja, L., Backen, A., Sloane, R., Menasce, L., Ryder, D., Krebs, M., Board, R., Clack, G., Hughes, A., Blackhall, F., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.545 · Cited by 255
Detection of K‐ras gene mutation by liquid biopsy in patients with pancreatic cancer
Kinugasa, H., Nouso, K., Miyahara, K., Morimoto, Y., Dohi, C., Tsutsumi, K., Kato, H., Matsubara, T., Okada, H., & Yamamoto, K. (2015) · Cancer · doi:10.1002/cncr.29364 · Cited by 239
Gasch, C., Bauernhofer, T., Pichler, M., Langer-Freitag, S., Reeh, M., Seifert, A. M., Mauermann, O., Izbicki, J. R., Pantel, K., & Riethdorf, S. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.188557 · Cited by 227
Niell, B. L., Freer, P. E., Weinfurtner, R. J., Arleo, E. K., & Drukteinis, J. S. (2017) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2017.06.004 · Cited by 226
Fabbri, F., Carloni, S., Zoli, W., Ulivi, P., Gallerani, G., Fici, P., Chiadini, E., Passardi, A., Frassineti, G. L., Ragazzini, A., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.015 · Cited by 223
Grillet, F., Bayet, E., Villeronce, O., Zappia, L., Lagerqvist, E. L., Lunke, S., Charafe-Jauffret, E., Pham, K., Molck, C., Rolland, N., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311447 · Cited by 215
Clark, T. A., Chung, J. H., Kennedy, M., Hughes, J. D., Chennagiri, N., Lieber, D. S., Fendler, B., Young, L., Zhao, M., Coyne, M., et al. (2018) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.05.004 · Cited by 200
Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study
Bork, U., Rahbari, N. N., Schölch, S., Reissfelder, C., Kahlert, C., Büchler, M. W., Weitz, J., & Koch, M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.88 · Cited by 196
Percutaneous Lung Biopsy: Technique, Efficacy, and Complications
Winokur, R., Sullivan, B., Madoff, D., & Pua, B. (2013) · Seminars in Interventional Radiology · doi:10.1055/s-0033-1342952 · Cited by 192
Bidard, F. C., Huguet, F., Louvet, C., Mineur, L., Bouché, O., Chibaudel, B., Artru, P., Desseigne, F., Bachet, J. B., Mathiot, C., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt176 · Cited by 192
MRI of Rectal Cancer: An Overview and Update on Recent Advances
Jhaveri, K. S., & Hosseini-Nik, H. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.14.14201 · Cited by 169
Taieb, J., Zaanan, A., Le Malicot, K., Julié, C., Blons, H., Mineur, L., Bennouna, J., Tabernero, J., Mini, E., Folprecht, G., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5225 · Cited by 154
Circulating Tumor Cells: Moving Biological Insights into Detection
Chen, L., Bode, A. M., & Dong, Z. (2017) · Theranostics · doi:10.7150/thno.18588 · Cited by 150
Hrebien, S., Citi, V., Garcia-Murillas, I., Cutts, R., Fenwick, K., Kozarewa, I., McEwen, R., Ratnayake, J., Maudsley, R., Carr, T. H., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz085 · Cited by 146
Wang, Z., Chen, R., Wang, S., Zhong, J., Wu, M., Zhao, J., Duan, J., Zhuo, M., An, T., Wang, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110780 · Cited by 138
CA 19-9 As a Marker in Addition to CEA to Monitor Colorectal Cancer
Stiksma, J., Grootendorst, D. C., & van der Linden, P. W. G. (2014) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2014.09.004 · Cited by 124
Thierry, A. R., Messaoudi, S. E., Mollévi, C., Raoul, J., Guimbaud, R., Pezet, D., Artru, P., Assénat, E., Borg, C., Mathonnet, M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx330 · Cited by 117
de Albuquerque, A., Kubisch, I., Breier, G., Stamminger, G., Fersis, N., Eichler, A., Kaul, S., & Stölzel, U. (2012) · Oncology · doi:10.1159/000335479 · Cited by 112
Ryan, B. M., Lefort, F., McManus, R., Daly, J., Keeling, P. W. N., Weir, D. G., & Kelleher, D. (2002) · Gut · doi:10.1136/gut.52.1.101 · Cited by 109
Yoon, H. J., Lee, H. Y., Lee, K. S., Choi, Y.-L., Ahn, M.-J., Park, K., Ahn, J. S., Sun, J.-M., Kim, J., Kim, T. S., et al. (2012) · Radiology · doi:10.1148/radiol.12112613 · Cited by 108
Plasma DNA Quantification in Lung Cancer Computed Tomography Screening
Sozzi, G., Roz, L., Conte, D., Mariani, L., Andriani, F., Vullo, S. L., Verri, C., & Pastorino, U. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1068oc · Cited by 103
Litvak, A. M., Cercek, A., Segal, N. H., Reidy‐Lagunes, D. L., Stadler, Z. K., Yaeger, R. D., Kemeny, N. E., Weiser, M. R., Pessin, M. S., & Saltz, L. B. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0085 · Cited by 103
Zhao, R., Cai, Z., Li, S., Cheng, Y., Gao, H., Liu, F., Wu, S., Liu, S., Dong, Y., Zheng, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14065 · Cited by 97
Denis, J. A., Patroni, A., Guillerm, E., Pépin, D., Benali-Furet, N., Wechsler, J., Manceau, G., Bernard, M., Coulet, F., Larsen, A. K., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.05.009 · Cited by 96
Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer
Riva, F., Dronov, O. I., Khomenko, D. I., Huguet, F., Louvet, C., Mariani, P., Stern, M.-H., Lantz, O., Proudhon, C., Pierga, J.-Y., et al. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.006 · Cited by 93
MRI in lung cancer: a pictorial essay
Hochhegger, B., Marchiori, E. D. S., Sedlaczek, O., Irion, K., Heußel, C. P., Ley, S., Ley‐Zaporozhan, J., Souza, A. S., & Kauczor, H.-U. (2011) · British Journal of Radiology · doi:10.1259/bjr/24661484 · Cited by 66
Reddy, R. M., Murlidhar, V., Zhao, L., Grabauskiene, S., Zhang, Z., Ramnath, N., Lin, J., Chang, A. C., Carrott, P. W., Lynch, W. R., et al. (2015) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2015.09.126 · Cited by 63
Ren, C., Han, C., Zhang, J., He, P., Wang, D., Wang, B., Zhao, P., & Zhao, X. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.12.8.15960 · Cited by 62
Juric, D., Ciruelos, E., Rubovszky, G., Campone, M., Loibl, S., Rugo, H., Iwata, H., Conte, P., Mayer, I., Kaufman, B., et al. (2019) · Cancer Research · doi:10.1158/1538-7445.sabcs18-gs3-08 · Cited by 62
Torphy, R. J., Tignanelli, C. J., Kamande, J. W., Moffitt, R. A., Hererra, S. G., Soper, S. A., & Yeh, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089474 · Cited by 60
Chevillet, J. R., Khokhlova, T. D., Giraldez, M. D., Schade, G. R., Starr, F., Wang, Y.-N., Gallichotte, E. N., Wang, K., Hwang, J. H., & Tewari, M. (2016) · Radiology · doi:10.1148/radiol.2016160024 · Cited by 54
Chen, I. M., Raymond, V. M., Geis, J. A., Collisson, E. A., Jensen, B. V., Hermann, K. L., Erlander, M. G., Tempero, M. A., & Johansen, J. S. (2017) · Oncotarget · doi:10.18632/oncotarget.22080 · Cited by 48
Alegre, E., Fusco, J. P., Restituto, P., Salas‐Benito, D., Rodriguez-Ruiz, M. E., Andueza, M. P., Pajares, M. J., Patiño‐García, A., Pío, R., Lozano, M. D., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-5282-9 · Cited by 42
Cao, S., Hu, Y., Gao, X., Liao, Q., & Zhao, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166406 · Cited by 36
Ziv, E., Bergen, M., Yarmohammadi, H., Boas, F. E., Petre, E. N., Sofocleous, C. T., Yaeger, R., Solit, D. B., Solomon, S. B., & Erinjeri, J. P. (2017) · Oncotarget · doi:10.18632/oncotarget.15278 · Cited by 35
Ziv, E., Erinjeri, J. P., Yarmohammadi, H., Boas, F. E., Petre, E. N., Gao, S., Shady, W., Sofocleous, C. T., Jones, D. R., Rudin, C. M., et al. (2016) · Radiology · doi:10.1148/radiol.2016160003 · Cited by 34
Zhou, C., Yuan, Z., Ma, W., Qi, L., Mahavongtrakul, A., Li, Y., Li, H., Gong, J., Fan, R. R., Li, J., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0671-8 · Cited by 33
Duarte, R., Bernardo, W. M., Sakai, C., Silva, G., Gonçalo Guedes, H., Kuga, R., Ide, E., Ishida, R., Sakai, P., & Guimarães Hourneaux de Moura, E. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s152147 · Cited by 31
Microsatellite instability in pancreatic cancer.
Eatrides, J. M., Coppola, D., Diffalha, S. A., Kim, R. D., Springett, G. M., & Mahipal, A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.e15753 · Cited by 26
Application of Liquid Biopsies in Cancer Targeted Therapy
Sumanasuriya, S., Lambros, M., & Bono, J. S. D. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.764 · Cited by 25
Gaba, R. C., Groth, J., Parvinian, A., Guzman, G., & Casadaban, L. C. (2015) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2014.12.610 · Cited by 24
Aieta, M., Facchinetti, A., Faveri, S. D., Manicone, M., Tartarone, A., Possidente, L., Lerose, R., Mambella, G., Calderone, G., Zamarchi, R., et al. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.05.002 · Cited by 24
Liquid Biopsy as Surrogate to Tissue in Lung Cancer for Molecular Profiling: A Meta-analysis
Mlika, M., Dziri, C., Zorgati, M. M., Khelil, M. B., & Mezni, F. E. (2018) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x14666180430144452 · Cited by 15
Tie, J., Semira, C., & Gibbs, P. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1386558 · Cited by 13
Monitoring microsatellite instability (MSI) in circulating tumor DNA by next-generation DNA-seq.
Deng, A., Yang, J., Lang, J., Jiang, Z., Wang, W., Yuan, D., Wang, X., & Tian, G. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.36.15_suppl.12025 · Cited by 11
Research works printed but not linked: 4
- Hricak H, 2016, Radiology 2018, 286, 764
- Sabari JK, 2018, J Natl Cancer Inst
- Ferry-Galow KV, 2018, J Oncol Pract, JOP1800092
- Tempero MA, 1987, Cancer Res, 47, 5501
Cited by
Recent advancements in optical biosensors for cancer detection
Kaur, B., Kumar, S., & Kaushik, B. K. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113805 · Cited by 433
Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR
Monticciolo, D. L., Newell, M. S., Moy, L., Lee, C. S., & Destounis, S. V. (2023) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2023.04.002 · Cited by 290
Surface Plasmon Resonance (SPR) Sensor for Cancer Biomarker Detection
Das, S., Devireddy, R., & Gartia, M. R. (2023) · Biosensors · doi:10.3390/bios13030396 · Cited by 223
“Plasma, saliva, urine, serum, and blood can all be used to detect these components [63].”
BackgroundNovel Approaches to Screening for Breast Cancer
Mann, R. M., Hooley, R., Barr, R. G., & Moy, L. (2020) · Radiology · doi:10.1148/radiol.2020200172 · Cited by 167
Small extracellular vesicles in cancer
Abhange, K., Makler, A., Wen, Y., Ramnauth, N., Mao, W., Asghar, W., & Wan, Y. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.03.015 · Cited by 131
Metadata
- Authors
- Underwood, J. J., Quadri, R. S., Kalva, S. P., Shah, H., Sanjeeviah, A. R., Beg, M. S., & Sutphin, P. D.
- Affiliations
- University of North Texas Health Science Center (US)
- ORCID
- Venue
- Radiology
- Published
- 2020-01
- Volume
- 294
- Issue
- 1
- Pages
- 5-17
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2990366580
- Cited by
- 87
- References
- 95
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 13 · 2023: 20 · 2022: 19 · 2021: 10 · 2020: 4
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Radiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Cancer Diagnosis and Treatment
- Keywords
- liquid biopsy, circulating tumor DNA, circulating tumor cells, cancer screening, cancer diagnosis, cancer surveillance, targeted therapy, treatment resistance, molecular profiling, precision medicine, image-guided interventions, non-invasive diagnosis
- MeSH terms
- Liquid Biopsy, Humans, Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.